Diaphragmatic stimulation treatmen… for Parkinson's (NCT04941326)
Improve breathing with diaphragmatic stimulation
- Trial ID
- NCT04941326
- Official Title
- Investigation of the Effect of Spinal Mobilization and Respiration Techniques on Posture and Respiratory Function in Parkinson's Patients
- Goal
- Improve breathing with diaphragmatic stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Abant Izzet Baysal University
- Study Type
- INTERVENTIONAL
- Enrollment
- 63 participants
- Conditions
- Parkinson Disease, Camptocormia, Restrictive Lung Disease
- Interventions
- Diaphragmatic stimulation treatment with PNF techniques, Costal mobilization, Breathing exercises, Spinal mobilization, Sham mobilization
Summary For Families
Aiming to ease the severe forward‑bending posture called camptocormia and boost breathing in people with Parkinson's who have restrictive lung signs. The program uses hands-on spinal and rib mobilization, diaphragmatic stimulation paired with PNF techniques that help retrain and activate the diaphragm, and targeted breathing exercises to increase chest wall mobility, improve diaphragm movement, and raise lung volumes; a sham mobilization group is used for comparison. Adults 50 to 85 with Parkinson's who volunteer and have a Modified Medical Research Council dyspnea score above 2 can join, while people with active COVID-19, recent chest or abdominal surgery, diaphragm mobility disorders, conditions that raise intra‑abdominal pressure, or chest masses are excluded.
Locations
- Abant Izzet Baysal University Faculty of Health Science, Bolu, Turkey (Türkiye)
- AIBU Physical Therapy and Rehabiltiation Department, Bolu, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Diaphragmatic stimulation treatment with PNF techniques. Aiming to ease the severe forward‑bending posture called camptocormia and boost breathing in people with Parkinson's who have restrictive lung signs. The program uses hands-on spinal and rib mobilization, diaphragmatic stimulation paired with PNF techniques that help retrain and activate the diaphragm, and targeted breathing exercises to increase chest wall mobility, improve diaphragm movement, and raise lung volumes; a sham mobilization group is used for comparison. Adults 50 to 85 with Parkinson's who volunteer and have a Modified Medical Research Council dyspnea score above 2 can join, while people with active COVID-19, recent chest or abdominal surgery, diaphragm mobility disorders, conditions that raise intra‑abdominal pressure, or chest masses are excluded.
- Who can participate?
- Participants must be between 50 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 4 years and 4 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has 2 groups, and 1 is a sham (a pretend version of the procedure) group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the sham group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- How many visits does this trial involve?
- The application group will receive spinal mobilization for 4 weeks.